Your browser doesn't support javascript.
loading
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram, Fahri; Sonmez, Alper; Haymana, Cem; Sabuncu, Tevfik; Dizdar, Oguzhan Sitki; Gurkan, Eren; Carlioglu, Ayse Kargili; Agbaht, Kemal; Ozdemir, Didem; Demirci, Ibrahim; Barcin, Cem; Salman, Serpil; Tetiker, Tamer; Balci, Mustafa Kemal; Kebapci, Nur; Ersoy, Canan; Yumuk, Volkan; Toth, Peter P; Satman, Ilhan.
Affiliation
  • Bayram F; Department of Endocrinology and Metabolism, Erciyes University, School of Medicine, Kayseri, Turkey.
  • Sonmez A; Department of Endocrinology and Metabolism, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey.
  • Haymana C; Department of Endocrinology and Metabolism, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey. cemhaymana@hotmail.com.
  • Sabuncu T; Department of Endocrinology and Metabolism, Harran University, School of Medicine, Sanliurfa, Turkey.
  • Dizdar OS; Department of Endocrinology and Metabolism, Kayseri Training and Research Hospital, Kayseri, Turkey.
  • Gurkan E; Department of Endocrinology and Metabolism, Mustafa Kemal University, School of Medicine, Hatay, Turkey.
  • Carlioglu AK; Department of Endocrinology and Metabolism, Erzurum Training and Research Hospital, Erzurum, Turkey.
  • Agbaht K; Department of Endocrinology and Metabolism, Private Defne Hospital, Hatay, Turkey.
  • Ozdemir D; Department of Endocrinology and Metabolism, Yildirim Beyazit University, School of Medicine, Ankara, Turkey.
  • Demirci I; Department of Endocrinology and Metabolism, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.
  • Barcin C; Department of Cardiology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey.
  • Salman S; Department of Endocrinology and Metabolism, Private Liv Hospital, Istanbul, Turkey.
  • Tetiker T; Department of Endocrinology and Metabolism, Cukurova University, School of Medicine, Adana, Turkey.
  • Balci MK; Department of Endocrinology and Metabolism, Akdeniz University, School of Medicine, Antalya, Turkey.
  • Kebapci N; Department of Endocrinology and Metabolism, Osmangazi University, School of Medicine, Eskisehir, Turkey.
  • Ersoy C; Department of Endocrinology and Metabolism, Uludag University, School of Medicine, Bursa, Turkey.
  • Yumuk V; Department of Endocrinology and Metabolism, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Toth PP; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Satman I; Preventive Cardiology, CGH Medical Center, Sterling, IL, USA.
Lipids Health Dis ; 19(1): 237, 2020 Nov 11.
Article in En | MEDLINE | ID: mdl-33176832

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Dyslipidemias / Cholesterol, LDL Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lipids Health Dis Journal subject: BIOQUIMICA / METABOLISMO Year: 2020 Type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Dyslipidemias / Cholesterol, LDL Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lipids Health Dis Journal subject: BIOQUIMICA / METABOLISMO Year: 2020 Type: Article Affiliation country: Turkey